These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21790200)

  • 1. Unraveling persistent host cell infection with Coxiella burnetii by quantitative proteomics.
    Vranakis I; De Bock PJ; Papadioti A; Samoilis G; Tselentis Y; Gevaert K; Tsiotis G; Psaroulaki A
    J Proteome Res; 2011 Sep; 10(9):4241-51. PubMed ID: 21790200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of potentially involved proteins in levofloxacin resistance mechanisms in Coxiella burnetii.
    Vranakis I; De Bock PJ; Papadioti A; Tselentis Y; Gevaert K; Tsiotis G; Psaroulaki A
    J Proteome Res; 2011 Feb; 10(2):756-62. PubMed ID: 21070068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of whole cell lysate from the intercellular bacterium Coxiella burnetii using two gel-based protein separation techniques.
    Samoilis G; Psaroulaki A; Vougas K; Tselentis Y; Tsiotis G
    J Proteome Res; 2007 Aug; 6(8):3032-41. PubMed ID: 17602512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of the whole cell lysate of two Coxiella burnetii strains using N-terminomics.
    Papadioti A; De Bock PJ; Vranakis I; Tselentis Y; Gevaert K; Psaroulaki A; Tsiotis G
    J Proteome Res; 2012 Jun; 11(6):3150-9. PubMed ID: 22559236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic screening for possible effector molecules secreted by the obligate intracellular pathogen Coxiella burnetii.
    Samoilis G; Aivaliotis M; Vranakis I; Papadioti A; Tselentis Y; Tsiotis G; Psaroulaki A
    J Proteome Res; 2010 Mar; 9(3):1619-26. PubMed ID: 20044831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative proteome profiling of C. burnetii under tetracycline stress conditions.
    Vranakis I; De Bock PJ; Papadioti A; Tselentis Y; Gevaert K; Tsiotis G; Psaroulaki A
    PLoS One; 2012; 7(3):e33599. PubMed ID: 22438959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of cellular proteome alterations in human influenza A virus-infected mammalian cell lines.
    Vester D; Rapp E; Gade D; Genzel Y; Reichl U
    Proteomics; 2009 Jun; 9(12):3316-27. PubMed ID: 19504497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coxiella burnetii glycomics and proteomics--tools for linking structure to function.
    Toman R; Skultety L; Ihnatko R
    Ann N Y Acad Sci; 2009 May; 1166():67-78. PubMed ID: 19538265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteome of Coxiella burnetii.
    Ihnatko R; Shaw E; Toman R
    Adv Exp Med Biol; 2012; 984():105-30. PubMed ID: 22711629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of proteomics towards deciphering the enigma of Coxiella burnetii.
    Vranakis I; Papadioti A; Tselentis Y; Psaroulaki A; Tsiotis G
    Proteomics Clin Appl; 2013 Jan; 7(1-2):193-204. PubMed ID: 23255407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Coxiella burnetii surface-exposed and cell envelope associated proteins using a combined bioinformatics plus proteomics strategy.
    Flores-Ramirez G; Jankovicova B; Bilkova Z; Miernyk JA; Skultety L
    Proteomics; 2014 Aug; 14(16):1868-81. PubMed ID: 24909302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of lipids in Coxiella burnetii infection.
    Gilk SD
    Adv Exp Med Biol; 2012; 984():199-213. PubMed ID: 22711633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term persistence of Coxiella burnetii after acute primary Q fever.
    Marmion BP; Storm PA; Ayres JG; Semendric L; Mathews L; Winslow W; Turra M; Harris RJ
    QJM; 2005 Jan; 98(1):7-20. PubMed ID: 15625349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of specific spectral markers of Coxiella burnetii isolates by MALDI-TOF mass spectrometry.
    Skultéty L; Hernychová L; Beregházyová E; Slabá K; Toman R
    Acta Virol; 2007; 51(1):55-8. PubMed ID: 17432945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic Identification of Coxiella burnetii Effector Proteins Targeted to the Host Cell Mitochondria During Infection.
    Fielden LF; Scott NE; Palmer CS; Khoo CA; Newton HJ; Stojanovski D
    Mol Cell Proteomics; 2021; 20():100005. PubMed ID: 33177156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vanin-1 controls granuloma formation and macrophage polarization in Coxiella burnetii infection.
    Meghari S; Berruyer C; Lepidi H; Galland F; Naquet P; Mege JL
    Eur J Immunol; 2007 Jan; 37(1):24-32. PubMed ID: 17163446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of action of Coxiella burnetii effectors inferred from host-pathogen protein interactions.
    Wallqvist A; Wang H; Zavaljevski N; Memišević V; Kwon K; Pieper R; Rajagopala SV; Reifman J
    PLoS One; 2017; 12(11):e0188071. PubMed ID: 29176882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coxiella burnetii stimulates production of RANTES and MCP-1 by mononuclear cells: modulation by adhesion to endothelial cells and its implication in Q fever.
    Meghari S; Desnues B; Capo C; Grau GE; Raoult D; Mege JL
    Eur Cytokine Netw; 2006 Dec; 17(4):253-9. PubMed ID: 17353158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial peptide mass fingerprinting analysis of proteins obtained by lysis of Coxiella burnetii cells.
    Skultéty L; Hernychová L; Toman R; Kroca M; Stulík J; Macela A
    Acta Virol; 2004; 48(1):29-33. PubMed ID: 15230472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coxiella burnetii secretion systems.
    McDonough JA; Newton HJ; Roy CR
    Adv Exp Med Biol; 2012; 984():171-97. PubMed ID: 22711632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.